ALTA

Enrollment by Site

Site2010.032010.022010.012009.122009.112009.10Total (since study beginning)
Baystate111321373
Duke12114449
California12102443
Chesapeake22230341
Mayo22224229
Louisiana01211129
Denver15031774
Utah255231279
Cleveland01046649
Vanderbilt02301244
Wake04354872
Seattle02111228
Totals102921252964= 178/ 610

Sub-Study Submission Instructions

Sub-study and Ancillary Study Proposals

Process and Format

Revised: 15 Sept 2008

For all proposals submitted to the Natural History and Pathogenesis Committees Definitions

  • “Sub-studies” are investigator-initiated studies that utilize previously collected data or samples from ARDSnet clinical trials. The studies may be related to the clinical issues addressed in the original trial, but the existing data and samples may also be used to address other questions.

  • “Ancillary studies” are investigator-initiated studies that involve an extension of the main goals of an ARDSnet trial, and usually require collection of additional data or samples. Additional funds, independent of the ARDSnet contracts, are generally required for ancillary studies.

Albuterol for the Treatment of ALI (ALTA)

Study status: Closed
Study dates: Aug 2007 — Sep 2008

A prospective, randomized trial of Aerosolized Albuterol vs. Placebo to test the safety and efficacy of aerosolized beta-2 adrenergic agonist therapy for improving clinical outcomes in patients with acute lung injury.

ClinicalTrials.Gov Registration Page

[restrict]

Consent Template

(There is nothing in the category)

ALTA Training

(There is nothing in the category)

FAQs

[collapse collapsed]

Specimens and mini-BAL Questions

(there are no FAQs in this category)


[/co

Syndicate content